BackgroundThere is extensive evidence that Holder pasteurization (HoP) (30 min at 62.5 degrees C) has harmful effects on the bioactivities of human milk (HM). We previously demonstrated that lowering HoP temperature is sufficient to inactivate Cytomegalovirus (HCMV). Here, we analyzed the effect of lowering time/temperature on the antiviral activity against HCMV and IgA levels of HM.MethodsEighty HM samples from five mothers were pasteurized in a range of temperature (62.5-56 degrees C) and time (40-10 min) in a conventional setting of Human Milk Bank. Unpasteurized HM from each mother was used as control. The samples were assayed against HCMV-AD169 strain in cell cultures and IgA levels were determined by ELISA.ResultsAll HM samples exhibited anti-HCMV activity, to a different extent. An improvement of antiviral activity was observed in samples treated at 60, 58 and 56 degrees C compared to those at 62.5 degrees C, with ID50 values near those of unpasteurized milk. Similarly, better retention in IgA levels was observed by reducing the temperature of treatment.ConclusionsWe demonstrated that a 2.5 degrees C reduction of heat treatment significantly preserved the IgA content and fully restored the anti-HCMV activity of HM, supporting this variant of HoP as a valid alternative to preserve HM bioactivities.ImpactThis work questions the standard HoP and opens the debate on whether the pasteurization temperature commonly used in Human Milk Banks should be lowered to better preserve the biological components of the milk.A reduction of HoP temperature at 60 degrees C determined a significant preservation of anti-HCMV activity and IgA content of donor HM, compared to standard HoP.This alternative HoP is highly feasible compared to other substitute pasteurization techniques, since it would employ the same pasteurizer equipment found in most Human Milk Banks.

Impact of time-temperature combinations on the anti-Cytomegalovirus activity and biological components of human milk

Arduino, Irene
First
;
Lembo, David;Donalisio, Manuela
Last
2023-01-01

Abstract

BackgroundThere is extensive evidence that Holder pasteurization (HoP) (30 min at 62.5 degrees C) has harmful effects on the bioactivities of human milk (HM). We previously demonstrated that lowering HoP temperature is sufficient to inactivate Cytomegalovirus (HCMV). Here, we analyzed the effect of lowering time/temperature on the antiviral activity against HCMV and IgA levels of HM.MethodsEighty HM samples from five mothers were pasteurized in a range of temperature (62.5-56 degrees C) and time (40-10 min) in a conventional setting of Human Milk Bank. Unpasteurized HM from each mother was used as control. The samples were assayed against HCMV-AD169 strain in cell cultures and IgA levels were determined by ELISA.ResultsAll HM samples exhibited anti-HCMV activity, to a different extent. An improvement of antiviral activity was observed in samples treated at 60, 58 and 56 degrees C compared to those at 62.5 degrees C, with ID50 values near those of unpasteurized milk. Similarly, better retention in IgA levels was observed by reducing the temperature of treatment.ConclusionsWe demonstrated that a 2.5 degrees C reduction of heat treatment significantly preserved the IgA content and fully restored the anti-HCMV activity of HM, supporting this variant of HoP as a valid alternative to preserve HM bioactivities.ImpactThis work questions the standard HoP and opens the debate on whether the pasteurization temperature commonly used in Human Milk Banks should be lowered to better preserve the biological components of the milk.A reduction of HoP temperature at 60 degrees C determined a significant preservation of anti-HCMV activity and IgA content of donor HM, compared to standard HoP.This alternative HoP is highly feasible compared to other substitute pasteurization techniques, since it would employ the same pasteurizer equipment found in most Human Milk Banks.
2023
94
3
956
964
https://www.nature.com/articles/s41390-023-02606-1
Arduino, Irene; Calvo, Javier; Rittà, Massimo; Cabeza, Sergio; Llobera, Marta; Lembo, David; Gayà, Antoni; Donalisio, Manuela
File in questo prodotto:
File Dimensione Formato  
Manuscript (1).doc

Accesso riservato

Descrizione: Arduino et al. pre-print
Tipo di file: PREPRINT (PRIMA BOZZA)
Dimensione 136.5 kB
Formato Microsoft Word
136.5 kB Microsoft Word   Visualizza/Apri   Richiedi una copia
Main_Document,_clean_version_(1) (1).doc

Accesso riservato

Descrizione: Arduino et al. post-print
Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 148 kB
Formato Microsoft Word
148 kB Microsoft Word   Visualizza/Apri   Richiedi una copia
Main_Document,_clean_version.pdf

Accesso aperto

Descrizione: Arduino et al. post-print
Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 326.49 kB
Formato Adobe PDF
326.49 kB Adobe PDF Visualizza/Apri
Manuscript.pdf

Accesso aperto

Descrizione: Arduino et al. pre-print
Tipo di file: PREPRINT (PRIMA BOZZA)
Dimensione 325.24 kB
Formato Adobe PDF
325.24 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1906633
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact